Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Exercise/Conversion of 39,000 TVTX shares, $984.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 39,000 | $984.8K |
| May 7, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 4,250 | n/a |
| Apr 23, 2026 | Travere Therapeutics, Inc. (TVTX) | Sale | 9,100 | $355.7K |
| Apr 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 14,000 | n/a |
| Feb 4, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 20,090 | n/a |
| Dec 30, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 60,000 | $1.24M |
| May 6, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 4,920 | n/a |
| Feb 13, 2025 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 8,000 | n/a |
| Feb 5, 2025 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 21,500 | n/a |
| Jan 24, 2025 | Travere Therapeutics, Inc. (TVTX) | Sale | 2,437 | $47.4K |